Smoking cessation intervention for severe mental ill health trial (SCIMITAR): A pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service

Health Technology Assessment

Volumn 19, Issue 25, 2015, Pages 1-148

  Peckham, Emily ^a   Man, Mei See ^b   Mitchell, Natasha ^a   Li, Jinshuo ^a   Becque, Taeko ^a   Knowles, Sarah ^c   Bradshaw, Tim ^c   Planner, Claire ^c   Parrott, Steve ^a   Michie, Susan ^d   Shepherd, Charles ^e   Gilbody, Simon ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; CITALOPRAM; CLOZAPINE; ELECTRONIC CIGARETTE; FLUOXETINE; FLUPENTIXOL DECANOATE; FLUPHENAZINE DECANOATE; HALOPERIDOL DECANOATE; LITHIUM CARBONATE; NICOTINE; NICOTINE DERIVATIVE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; NOSE SPRAY; OLANZAPINE; PAROXETINE; PROCHLORPERAZINE; PROCYCLIDINE; QUETIAPINE; RISPERIDONE; TRIHEXYPHENIDYL; VARENICLINE; ZUCLOPENTHIXOL;

ACUPUNCTURE; ARTICLE; BESPOKE SMOKING CESSATION INTERVENTION; BIPOLAR DISORDER; BODY MASS; BURNING MOUTH SYNDROME; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEPRESSION; ECONOMIC EVALUATION; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; GENERAL PRACTITIONER; HEADACHE; HEALTH CARE COST; HUMAN; HYPNOSIS; INHALER; MENTAL HEALTH; MOTIVATION; NICOTINE REPLACEMENT THERAPY; PARANOID SCHIZOPHRENIA; PATIENT HEALTH QUESTIONNAIRE 9; PILOT STUDY; PSYCHOSIS; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SHORT FORM 12; SMOKING CESSATION PROGRAM; SOMNOLENCE; SUICIDE; TOBACCO DEPENDENCE; WEIGHT GAIN; ADOLESCENT; ADULT; CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MENTAL PATIENT; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; COST-BENEFIT ANALYSIS; ENGLAND; FEMALE; HUMANS; MALE; MENTALLY ILL PERSONS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PILOT PROJECTS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84926338836     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta19250     Document Type: Article

References (73)

1. McDonald C. Cigarette smoking in patients with schizophrenia. Br J Psychiatry 2000;176:596–7. http://dx.doi.org/10.1192/bjp.176.6.596-b
2. Olincy A, Young DA, Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry 1997;42:1–5. http://dx.doi.org/10.1016/S0006-3223(96)00302-2
3. McCreadie R, Kelly C. Patients with schizophrenia who smoke. Br J Psychiatry 2000;176:109. http://dx.doi.org/10.1192/bjp.176.2.109
4. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness a population-based prevalence study. J Am Med Assoc 2000;284:2606–10. http://dx.doi.org/10.1001/jama.284.20.2606
5. Phelan M, Stradins L, Morrison S. Physical health of people with severe mental illness: can be improved if primary care and mental health professionals pay attention to it. BMJ 2001;322:443–4. http://dx.doi.org/10.1136/bmj.322.7284.443
6. Weiser M, Reichenberg A, Grotto I. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry 2004;161:1219–23. http://dx.doi.org/10.1176/appi.ajp.161.7.1219
7. Williams JM, Ziedonis DM, Abanyie F. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 2005;79:323–35. http://dx.doi.org/10.1016/j.schres.2005.04.016
8. Himelhoch S, Daumit G. To whom do psychiatrists offer smoking-cessation counseling? Am J Psychiatry 2003;160:2228–30. http://dx.doi.org/10.1176/appi.ajp.160.12.2228
9. Baker A, Richmond R, Haile M, Lewin T, Carr R. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Res 2006;150:141–52. http://dx.doi.org/10.1016/j.psychres.2006.05.021
10. Carosella AM, Ossip-Klein DJ, Owens CA. Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav 1999;24:331–4. http://dx.doi.org/10.1016/S0306-4603(98)00096-3
11. Esterberg ML, Compton ML. Smoking behaviour in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model. Soc Sci Med 2005;61:293–303. http://dx.doi.org/10.1016/j.socscimed.2004.11.057
12. Addington J, el-Guebaly N, Addington D, Hodgins D. Readiness to stop smoking in schizophrenia. Can J Psychiatry 1997;42:49–52.
13. Sacco KA, Termine A, Seyal A. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 2005;62:649–59. http://dx.doi.org/10.1001/archpsyc.62.6.649
14. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010;196:116–21. http://dx.doi.org/10.1192/bjp.bp.109.067512
15. Kendrick T, Burns T, Freeling P. Provision of care to general practice patients with disabling long-term mental illness: a survey in 16 practices. Br J Gen Pract 1994;44:301–5.
16. Burns T, Cohen A. Items of service payments for general practitioner care of severely mentally ill patients: does the money matter? Br J Gen Pract 1998;48:1415–16.
17. Jochelson K, Majrowski B. Clearing the Air: Debating Smoke-free Policies in Psychiatric Units. London: The King’s Fund; 2006.
18. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction 2009;104:719–33. http://dx.doi.org/10.1111/j.1360-0443.2009.02545.x
19. Ratschen E, Britton J, Doody GA, Leonardi-Bee J, McNeill A. Tobacco dependence, treatment and smoke-free policies: a survey of mental health professionals’ knowledge and attitudes. Gen Hosp Psych 2009;31:576–82. http://dx.doi.org/10.1016/j.genhosppsych.2009.08.003
20. Lester H. Shared care for people with mental illness: a GP’s perspective. Adv Psychiatr Treat 2005;11:133–9. http://dx.doi.org/10.1192/apt.11.2.133
21. National Institute for Health and Care Excellence (NICE). NICE Public Health Guidance 48, Smoking Cessation in Secondary Care in Acute, Maternity and Mental Health Services. London: NICE; 2013.
22. West R. Defining and assessing nicotine dependence in humans. In Corrigall WA, editor. Understanding Nicotine and Tobacco Addiction. Chichester: John Wiley & Sons; 2006. pp. 36–63. http://dx.doi.org/10.1002/9780470029237.ch4
23. Balfour DJK. The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus. Nicotine Tob Res 2004;6:899–912. http://dx.doi.org/10.1080/14622200412331324965
24. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007;9:315–27. http://dx.doi.org/10.1080/14622200701188919
25. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;3:CD000146.
26. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smoke. Addiction 2004;99:29–38. http://dx.doi.org/10.1111/j.1360-0443.2004.00540.x
27. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev 2004;4:CD000165.
28. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2005;2:CD001292. http://dx.doi.org/10.1002/14651858.CD001292.pub2
29. Lancaster T, Stead LF. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2005;2:CD001007. http://dx.doi.org/10.1002/14651858.CD001007.pub2
30. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2005;3:CD001118. http://dx.doi.org/10.1002/14651858.CD001118.pub2
31. Lancaster T, Perera R, Stead LF. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2006;3:CD002850. http://dx.doi.org/10.1002/14651858.CD002850.pub2
32. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007;3:CD006103. http://dx.doi.org/10.1002/14651858.CD006103.pub3
33. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;1:CD000031. http://dx.doi.org/10.1002/14651858.CD000031.pub3
34. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation (Review). Cochrane Database Syst Rev 2007;3:CD002850.
35. National Institute for Health and Clinical Excellence (NICE). Brief Interventions and Referral for Smoking Cessation in Primary Care and Other Settings: NICE Public Health Intervention Guidance. London: NICE; 2006.
36. National Institute for Health and Clinical Excellence (NICE). Smoking Cessation Services, Including the Use of Pharmacotherapies, in Primary Care, Pharmacies, Local Authorities and Workplaces. London: NICE; 2007.
37. Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D. ‘Cut down to quit’ with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 2008;12(2).
38. Pfizer Labs. Medication Guide Chantix®. Revised 2012. NHS Information Centre for Health and Social Care. URL: www.fda.gov/downloads/Drugs/DrugSafety/ucm088569.pdf (accessed 19 May 2014).
39. Schroeder SA. A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA 2009;301:522–31. http://dx.doi.org/10.1001/jama.2008.982
40. McEwen A, West R, McRobbie H. Effectiveness of specialist group treatment for smoking cessation vs. one-to-one treatment in primary care. Addict Behav 2006;31:1650–60. http://dx.doi.org/10.1016/j.addbeh.2005.12.014
41. Aveyard P, West R. Managing smoking cessation. BMJ 2007;335:37–41. http://dx.doi.org/10.1136/bmj.39252.591806.47
42. McEwen A, Hajek P, McRobbie H, West R. Smoking Cessation Manual: A Guide for Councellors and Practitioners. London: Blackwell Publishing Ltd; 2006. http://dx.doi.org/10.1002/9780470757864
43. Royal College of General Practitioners and Royal College of Psychiatrists. Primary Care Guidance on Smoking and Mental Health. London: The forum for mental health in primary care; 2008.
44. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works? Addiction 2010;105:1176–89.
45. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2010;6:CD007253. http://dx.doi.org/10.1002/14651858.CD007253.pub2
46. British Medical Association and NHS Employers. Revisions to the GMS Contract, 2006/7. Delivering Investment in General Practice. London: British Medical Association; 2006.
47. NHS Employers/Department of Health. The Practice can Produce a Register of People with Schizophrenia, Bipolar Disorder and Other Psychoses. Leeds: NHS Information Centre for Health and Social Care; 2012. URL: https://mqi.ic.nhs.uk/IndicatorDefaultView.aspx?ref=1.07.09 (accessed 19 May 2014).
48. NHS Employers/Department of Health. The Percentage of Patients with Schizophrenia, Bipolar Affective Disorder and Other Psychoses with a Review Recorded in the Preceding 15 Months. In the Review there Should be Evidence that the Patient has been Offered Routine Health Promotion and Prevention Advice Appropriate to their Age, Gender and Health Status. Leeds: NHS Information Centre for Health and Social Care; 2011. URL: https://mqi.ic.nhs.uk/IndicatorDefaultView.aspx?ref=1.07.05 (accessed 19 May 2014).
49. Department of Health. Mental Health Act. London: Her Majesty’s Stationery Office; 1983.
50. National Institute for Health and Care Excellence (NICE). Smoking Cessation in Secondary Care: Acute, Maternity and Mental Health Services. London: NICE; 2013.
51. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694–6. http://dx.doi.org/10.1136/bmj.321.7262.694
52. Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:979–83. http://dx.doi.org/10.1136/bmj.a1655
53. Cohen A, Hove M. Physical Health of the Severe and Enduring Mentally Ill. London: Sainsbury Centre for Mental Health; 2001.
54. Department of Health. Mental Capacity Act. London: The Stationery Office; 2005.
55. British Medical Association and NHS Employers. Revisions to the GMS Contract, 2008/9. Delivering Investment in General Practice. London: British Medical Association; 2008.
56. National Institute for Health and Clinical Excellence. Smoking Cessation Services in Primary Care, Pharmacies, Local Authories and Workplaces, Particularly for Manual Working Groups, Pregnant Women and Hard to Reach Communities. London: NICE; 2008.
57. Hartley H. ‘The Tip of the Iceberg’ – A Review of Smoking Cessation Work: Mental Health and Learning Disabilities. Leeds: Leeds Community Healthcare, Leeds NHS; 2009.
58. Department of Health (DH). NHS Stop Smoking Services: Service and Monitoring Guide 2009/10. London: DH; 2009.
59. Abraham C, Michie S. A taxonomy of behaviour change techniques used in interventions. Health Psychol 2008;27:379–87. http://dx.doi.org/10.1037/0278-6133.27.3.379
60. Michie S, Hyder N, Walia A, West R. Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2011;36:315–19. http://dx.doi.org/10.1016/j.addbeh.2010.11.016
61. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Addiction 1991;86:1119–27. http://dx.doi.org/10.1111/j.1360-0443.1991.tb01879.x
62. Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: a UK validation of the PHQ9 and CORE-OM. Br J Gen Pract 2007;57:650–2.
63. Ware JE, Kosinski M, Dewey JE. How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: Quality Metric Inc.; 2000.
64. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. No. 63 London: BMA and RPS; 2012.
65. Prescribing and Primary Care team, Health and Social Care Information Centre Health and Social Care Information Centre. Prescription Cost Analysis England 2012. Leeds: Health and Social Care Information Centre; 2013.
66. Department of Health (DH). Reference Costs 2011–12. London: DH; 2012.
67. Department of Health (DH). Reference Costs 2009–10. London: DH; 2011.
68. Curtis L. Unit Costs of Health and Social Care 2012. Personal Social Services Research Unit, University of Kent, 2012.
69. Wu Q, Parrott S, Godfrey C, Gilbert H, Nazareth I, Leurent B, et al. Cost-Effectiveness of computer-tailored Smoking Cessation Advice in Primary care: a randomised trial (ESCAPE). Nicotine Tob Res 2014;16:270–8. http://dx.doi.org/10.1093/ntr/ntt136
70. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 2004;13:1203–10. http://dx.doi.org/10.1002/hec.901
71. Royal College of Physicians. Smoking and Mental Health: A Report by the Tobacco Advisory Group. London: Royal College of Physicians; 2013.
72. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299–303. http://dx.doi.org/10.1111/j.1360-0443.2004.00995.x
73. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014;348:g115. http://dx.doi.org/10.1136/bmj.g1151